Key result
This review outlines the basic characteristics, production, and clinical applications of radiopharmaceuticals for radiosynoviorthesis, including guidelines and efficacy in different disease conditions.
This review provides an overview of the characteristics, production, and clinical applications of radiopharmaceuticals used in radiosynoviorthesis.
May guide radiopharmaceutical selection in radiosynoviorthesis; leaves open need for comparative trials before practice change.
This overview describes the basic characteristics and chemistry, production and the clinical applications and use of radiopharmaceuticals pertaining to radiosynoviorthesis (RSO). In each of the case scenarios, the physical and clinical parameters that serve as determinants and govern the choice of a particular radionuclide employed for RSO are discussed. References have been drawn on the fundamentals of RSO where applicable, including a brief review of the principles and mechanism of action, the indication and efficacy of RSO in different disease conditions and suggestions set out by the current guideline recommendations.
No takes yet. Share an insight, caveat, or question.
Chakraborty et al. (2022) conducted a review in Joint diseases requiring radiosynoviorthesis. Radiopharmaceuticals for radiosynoviorthesis (RSO) was evaluated. This review outlines the basic characteristics, production, and clinical applications of radiopharmaceuticals for radiosynoviorthesis, including guidelines and efficacy in different disease conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: